CEO & Chairman of the Board, 10% Owner of Pain Therapeutics (PTIE, Financial) Remi Barbier sells 22,391 shares of PTIE on 08/04/2010 at an average price of $5.71 a share.
Pain Therapeutics has a market cap of $241.2 million; its shares were traded at around $5.66 with and P/S ratio of 11.7.
PTIE is in the portfolios of Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
Pain Therapeutics has a market cap of $241.2 million; its shares were traded at around $5.66 with and P/S ratio of 11.7.
PTIE is in the portfolios of Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 27,243 shares of PTIE stock on 07/07/2010 at the average price of 5.35. Remi Barbier owns at least 6,071,447 shares after this. The price of the stock has increased by 5.79% since.
- Sell: CEO and Chairman of Board, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 06/03/2010 at the average price of 5.53. Remi Barbier owns at least 6,121,447 shares after this. The price of the stock has increased by 2.35% since.
- Sell: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 6,576 shares of PTIE stock on 05/06/2010 at the average price of 5.61. Remi Barbier owns at least 6,171,447 shares after this. The price of the stock has increased by 0.89% since.
- Sell: CEO and Chairman of BOD, 10% Owner Remi Barbier sold 43,424 shares of PTIE stock on 05/05/2010 at the average price of 5.91. Remi Barbier owns at least 6,178,023 shares after this. The price of the stock has decreased by 4.23% since.
- Sell: CEO and Chairman of Board, 10% Owner Remi Barbier sold 5,800 shares of PTIE stock on 04/07/2010 at the average price of 6.23. Remi Barbier owns at least 6,221,447 shares after this. The price of the stock has decreased by 9.15% since.
Directors and Officers Recent Trades:
- Sell: Chief Scientific Officer Grant Schoenhard sold 1,500 shares of PTIE stock on 07/16/2010 at the average price of 5.54. Grant Schoenhard owns at least 48,157 shares after this. The price of the stock has increased by 2.17% since.
- Sell: Chief Scientific Officer Grant Schoenhard sold 1,500 shares of PTIE stock on 06/16/2010 at the average price of 5.45. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has increased by 3.85% since.
- Sell: Chief Scientific Officer Grant Schoenhard sold 10,979 shares of PTIE stock on 05/27/2010 at the average price of 5.74. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has decreased by 1.39% since.
- Sell: Chief Scientific Officer Grant Schoenhard sold 2,486 shares of PTIE stock on 05/19/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has decreased by 1.91% since.
- Sell: Chief Scientific Officer Grant Schoenhard sold 13,035 shares of PTIE stock on 05/18/2010 at the average price of 5.77. Grant Schoenhard owns at least 48,187 shares after this. The price of the stock has decreased by 1.91% since.
